BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haddadin Z, Krueger K, Thomas LD, Overton ET, Ison M, Halasa N. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. Am J Transplant 2021;21:938-49. [PMID: 32885604 DOI: 10.1111/ajt.16295] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Yamada M, Matsumoto E, Thomas CP, Carlson JR, Klutts JS, Kumar B, Streit JA, Swee ML. Case Report: Severe COVID-19 in a Kidney Transplant Recipient Without Humoral Response to SARS-CoV-2 mRNA Vaccine Series. Transplant Direct 2021;7:e743. [PMID: 34386580 DOI: 10.1097/TXD.0000000000001193] [Reference Citation Analysis]
2 Caglioti A, Rania V, Vocca C, Marcianò G, Arcidiacono V, Catarisano L, Casarella A, Basile E, Colosimo M, Palleria C, Mazzuca D, Di Mizio G, De Sarro C, Pileggi C, De Sarro G, Gallelli L. Effectiveness and Safety of ANTI SARS-CoV-2 Vaccination in Transplant Patients Treated with Immunosuppressants: A Real-World Pilot Study with a 1-Year Follow-Up. Applied Sciences 2022;12:6103. [DOI: 10.3390/app12126103] [Reference Citation Analysis]
3 Ryu H, Narayanan N, Bhatt PJ. Prevention of infection and optimizing vaccination in the solid organ transplant candidate and recipient. Curr Opin Organ Transplant 2021;26:445-55. [PMID: 34227584 DOI: 10.1097/MOT.0000000000000902] [Reference Citation Analysis]
4 Blumberg EA, Manuel O, Sester M, Ison MG. The future of SARS-CoV-2 vaccines in transplant recipients: To be determined. Am J Transplant 2021;21:2629-30. [PMID: 33829628 DOI: 10.1111/ajt.16598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Heldman MR, Limaye AP. SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? J Am Soc Nephrol 2021;32:1021-4. [PMID: 33762353 DOI: 10.1681/ASN.2021010023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Reischig T, Kacer M, Vlas T, Drenko P, Kielberger L, Machova J, Topolcan O, Kucera R, Kormunda S. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. Am J Transplant 2021. [PMID: 34860470 DOI: 10.1111/ajt.16902] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
7 Krueger KM, Halasa N, Ison MG. SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost? Am J Kidney Dis 2021:S0272-6386(21)00969-0. [PMID: 34922790 DOI: 10.1053/j.ajkd.2021.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 de St Maurice A, Martin-Blais R, Halasa N. Preparing for the 2020-2021 influenza season. Pediatr Transplant 2021;25:e14025. [PMID: 33904211 DOI: 10.1111/petr.14025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Ison MG, Blumberg E, Halasa N, Kaul D, Theodoropoulos NM, Wolfe CR. Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research. Am J Transplant 2021. [PMID: 34241964 DOI: 10.1111/ajt.16758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
10 Eberhardt CS, Balletto E, Cornberg M, Mikulska M. Coronavirus disease 2019 vaccination in transplant recipients. Curr Opin Infect Dis 2021;34:275-87. [PMID: 34074880 DOI: 10.1097/QCO.0000000000000739] [Reference Citation Analysis]
11 Miele M, Busà R, Russelli G, Sorrentino MC, Di Bella M, Timoneri F, Mularoni A, Panarello G, Vitulo P, Conaldi PG, Bulati M. Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients. Am J Transplant 2021;21:2919-21. [PMID: 34058052 DOI: 10.1111/ajt.16702] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 31.0] [Reference Citation Analysis]
12 Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol 2021;99:108021. [PMID: 34352567 DOI: 10.1016/j.intimp.2021.108021] [Reference Citation Analysis]
13 Vnučák M, Graňák K, Beliančinová M, Jeseňák M, Macháleková KK, Benko J, Samoš M, Dedinská I. Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine-case report. NPJ Vaccines 2022;7:30. [PMID: 35236844 DOI: 10.1038/s41541-022-00445-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]